SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 26 filers reported holding SILENCE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,675,000 | +52.0% | 700,000 | 0.0% | 0.03% | +52.9% |
| Q3 2022 | $7,025,000 | +4.9% | 700,000 | +23.9% | 0.02% | +13.3% |
| Q2 2022 | $6,695,000 | -35.9% | 565,000 | +2.7% | 0.02% | -25.0% |
| Q1 2022 | $10,450,000 | -20.5% | 550,000 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $13,140,000 | +43.4% | 550,000 | +23.8% | 0.02% | +33.3% |
| Q3 2021 | $9,160,000 | -21.2% | 444,444 | 0.0% | 0.02% | -21.7% |
| Q2 2021 | $11,629,000 | +13.8% | 444,444 | 0.0% | 0.02% | +9.5% |
| Q1 2021 | $10,222,000 | – | 444,444 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |